FOR RELEASE 3/11/2008, Tuesday
ROCHESTER, N.Y. — The Shandong Institute of Pharmaceutical Research has named two Bausch & Lomb executives as distinguished research fellows, the Institute’s highest scientific honor. Praveen Tyle, Ph.D., chief scientific officer, and Erning Xia, research fellow and coordinator for Bausch & Lomb Freda research and development, were presented with the appointments in a recent ceremony.
Bausch & Lomb Freda, the company’s pharmaceutical joint venture in the region, has recently relocated its research and development activities to the Institute’s new facility, located in Jinan, China.
“We’re proud to be partnering with the Shandong Institute of Pharmaceutical Research for ongoing discovery and development endeavors,” said Dr. Tyle. “We’re now conducting more global research at the site, and the increased space at the new facility affords us the opportunity to grow as Bausch & Lomb grows.”
Bausch & Lomb is the eye health company dedicated to perfecting vision and enhancing life for consumers around the world. Its core businesses include soft and rigid gas permeable contact lenses and lens care products, and ophthalmic surgical and pharmaceutical products. The Bausch & Lomb name is one of the best known and most respected healthcare brands in the world. Founded in 1853, the Company is headquartered in Rochester, N.Y., and employs approximately 13,000 people worldwide. Its products are available in more than 100 countries. More information about the Company can be found at www.bausch.com.
The website you are about to visit is not affiliated with Bausch + Lomb Incorporated. Bausch + Lomb is not responsible for the content, format, maintenance, or policies of the website you are about to enter and does not monitor non-affiliated websites for accuracy. Links to non-affiliated websites are provided as a convenience; they do not constitute an endorsement or support of any programs, products, or services associated with the website.